Eden Research (LON:EDEN) Stock Price Down 0.2% – What’s Next?

Eden Research plc (LON:EDEN)’s share price was down 0.2% during mid-day trading on Friday . The stock traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). Approximately 10,000 shares changed hands during trading, a decline of 99% from the average daily volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 0.2 %

The stock’s 50 day simple moving average is GBX 3.88 and its 200 day simple moving average is GBX 3.95. The firm has a market cap of £19.17 million, a PE ratio of -12.59 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Buying and Selling

In other news, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Also, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). 14.02% of the stock is owned by company insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.